These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32563354)

  • 21. Pemphigus and mucous membrane pemphigoid: An update from diagnosis to therapy.
    Buonavoglia A; Leone P; Dammacco R; Di Lernia G; Petruzzi M; Bonamonte D; Vacca A; Racanelli V; Dammacco F
    Autoimmun Rev; 2019 Apr; 18(4):349-358. PubMed ID: 30738958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Involvement of mucous membranes in autoimmune bullous diseases].
    Günther C
    Hautarzt; 2016 Oct; 67(10):774-779. PubMed ID: 27631412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bullous diseases of the pemphigus group].
    Portugal C; Rodrigues M; de Campos C
    Rev Port Estomatol Cir Maxilofac; 1982; 23(4):471-81. PubMed ID: 7188101
    [No Abstract]   [Full Text] [Related]  

  • 24. Blistering diseases in the mature patient.
    Lakoš Jukić I; Jerković Gulin S; Marinović B
    Clin Dermatol; 2018; 36(2):231-238. PubMed ID: 29566927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical response to rituximab and improvement in quality of life in patients with bullous pemphigoid and mucous membrane pemphigoid.
    Rashid H; Meijer JM; Bolling MC; Horváth B
    Br J Dermatol; 2022 Apr; 186(4):721-723. PubMed ID: 34747507
    [No Abstract]   [Full Text] [Related]  

  • 26. Neonatal pemphigus in an infant born to a mother with serologic evidence of both pemphigus vulgaris and gestational pemphigoid.
    Panko J; Florell SR; Hadley J; Zone J; Leiferman K; Vanderhooft S
    J Am Acad Dermatol; 2009 Jun; 60(6):1057-62. PubMed ID: 19467379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoimmune bullous diseases.
    Rye B; Webb JM
    Am Fam Physician; 1997 Jun; 55(8):2709-18. PubMed ID: 9191456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoimmune aspects of pemphigus vulgaris and mucosal pemphigoid.
    Sciubba JJ
    Adv Dent Res; 1996 Apr; 10(1):52-6. PubMed ID: 8934925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New immunomodulating drugs in autoimmune blistering diseases.
    Korman NJ
    Dermatol Clin; 2001 Oct; 19(4):637-48, viii. PubMed ID: 11705351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid (MMP).
    Maley A; Warren M; Haberman I; Swerlick R; Kharod-Dholakia B; Feldman R
    J Am Acad Dermatol; 2016 May; 74(5):835-40. PubMed ID: 26936298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of subepidermal immunobullous diseases.
    Wojnarowska F; Kirtschig G; Khumalo N
    Clin Dermatol; 2001; 19(6):768-77. PubMed ID: 11705687
    [No Abstract]   [Full Text] [Related]  

  • 32. Rituximab therapy in patients with bullous pemphigoid: A retrospective study of 20 patients.
    Polansky M; Eisenstadt R; DeGrazia T; Zhao X; Liu Y; Feldman R
    J Am Acad Dermatol; 2019 Jul; 81(1):179-186. PubMed ID: 30923002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rituximab in childhood and juvenile autoimmune bullous diseases as first-line and second-line treatment: a case series of 13 patients.
    Kianfar N; Dasdar S; Mahmoudi H; Tavakolpour S; Balighi K; Daneshpazhooh M
    J Dermatolog Treat; 2022 Mar; 33(2):869-874. PubMed ID: 32589481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coexistence of pemphigus vulgaris and bullous pemphigoid in the upper aerodigestive tract.
    Tabuchi K; Nomura M; Murashita H; Fujisawa Y; Tsuji S; Okubo H; Hara A
    Auris Nasus Larynx; 2006 Jun; 33(2):231-3. PubMed ID: 16168587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bullous autoimmune dermatoses.
    Hofmann SC; Juratli HA; Eming R
    J Dtsch Dermatol Ges; 2018 Nov; 16(11):1339-1358. PubMed ID: 30395395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology.
    Santi CG; Gripp AC; Roselino AM; Mello DS; Gordilho JO; Marsillac PF; Porro AM
    An Bras Dermatol; 2019 Apr; 94(2 Suppl 1):33-47. PubMed ID: 31166405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sustained clinical response to rituximab in a case of life-threatening overlap subepidermal autoimmune blistering disease.
    Li Y; Foshee JB; Sontheimer RD
    J Am Acad Dermatol; 2011 Apr; 64(4):773-8. PubMed ID: 20494477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The autoimmune bullous diseases.
    Wakelin SH; Black MM
    J R Coll Physicians Lond; 1997; 31(4):364-8. PubMed ID: 9263961
    [No Abstract]   [Full Text] [Related]  

  • 39. Rituximab therapy for refractory autoimmune bullous diseases: A multicenter, open-label, single-arm, phase 1/2 study on 10 Japanese patients.
    Kurihara Y; Yamagami J; Funakoshi T; Ishii M; Miyamoto J; Fujio Y; Kakuta R; Tanikawa A; Aoyama Y; Iwatsuki K; Ishii N; Hashimoto T; Nishie W; Shimizu H; Kouyama K; Amagai M
    J Dermatol; 2019 Feb; 46(2):124-130. PubMed ID: 30585649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of pemphigus and pemphigoids.
    López-Jornet P; Bermejo-Fenoll A
    Med Oral Patol Oral Cir Bucal; 2005; 10(5):410-1. PubMed ID: 16264376
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.